Giposart tab 32mg 28 pc

$8.98

Giposart tab 32mg 28 pc

5 in stock

Quantity:

Description

Composition
Active substance:
Atacand (candesartan).
Excipients:
Lactose monohydrate – 174 mg, corn starch – 40 mg, giproloza (viscosity, water 25B ° C, 5% – 75-150 cps) – 4 mg, giproloza (viscosity, water 25B ° C, 5% – 1500-3000 cps) – 4 mg macrogol 6000 – 5.2 mg magnesium stearate – 0.8 mg. 14 pcs. – blisters (1) – packs cardboard. 14 pcs. – blisters (2) – packs cardboard. 14 pcs. – blisters (4) – packs cardboard.
Product form:
GIPOSART tab. 32 mg of 14, 28 or 56 pieces. Tablets white, round, flat, with Valium on one side and with an engraving “32” on the other hand. 1 tab. candesartan cilexetil 32 mg.
Contraindications
Severe hepatic insufficiency and / or cholestasis, pregnancy, lactation (breast-feeding), increased sensitivity to candesartan.
Dosage
32 mg
Indications
Arterial hypertension.
Interaction with other drugs
While the use of potassium supplements, potassium-sparing diuretics, food supplements containing potassium or potassium salt substitutes may develop hyperkalemia. Drugs that affect the RAAS, may increase the concentration of urea and creatinine in the blood in patients with bilateral renal artery stenosis or artery to a solitary kidney. Simultaneous treatment with diuretics and other antihypertensive drugs increases the risk of hypotension. Candesartan increases the concentration of lithium in blood serum and increases the risk of toxic reactions.
pharmachologic effect
Pharmacological group:
Angiotensin II receptor antagonist.
Pregnancy and breast-feeding
Candesartan is contraindicated during pregnancy and lactation (breastfeeding). Application for violations of liver function is contraindicated in severe liver failure. For patients with impaired liver function starting dose is 2mg. Use in renal function is not recommended for patients with severe renal failure (creatinine clearance less than 15 mL / min) with a primary hyperaldosteronism. When applied in patients with renal insufficiency should periodically monitor the level of potassium, and creatinine in the blood plasma. For patients with impaired renal function, the initial dose is 2 mg.
side effects
CNS side effects dizziness. Respiratory system cough, flu-like symptoms, rhinitis, pharyngitis, increased frequency of respiratory infections. From the digestive system stomach pain. Cardio-vascular and peripheral edema. Other possible back pain.
special instructions
Not recommended for patients with severe renal failure (creatinine clearance less than 15 mL / min) with a primary hyperaldosteronism. Before starting treatment with candesartan should carry out the correction of violations of water-electrolyte balance. When applied in patients with renal insufficiency should periodically monitor the level of potassium, and creatinine in the blood plasma.
To apply caution in patients with hemodynamic disturbances caused by aortic or mitral stenosis, obstructive hypertrophic cardiomyopathy. It should be borne in mind that in patients with ischemic cardiomyopathy, ischemic cerebrovascular disease, sudden hypotension can lead to myocardial infarction or stroke.
Effects on ability to drive vehicles and management mechanisms
If necessary, use in patients involved in potentially hazardous activities (including driving motor vehicles) should be borne in mind that candesartan can cause dizziness and weakness.
Dosing and Administration
Taken orally 1 times / day. Starting dose – 4 mg supporting – 8 mg maximum – 16 mg. For patients with impaired liver function and / or renal initial dose is 2 mg.
Information
Appearance may differ from that depicted in the picture. There are contraindications. You need to read the manual or consult with a specialist

Additional information

Weight0.100 kg
Manufacturer

QUINACRINE

There are no reviews yet.

Add your review